{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:46:52Z","timestamp":1793710012046,"version":"4.6.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA247471"],"award-info":[{"award-number":["R01CA247471"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA247471"],"award-info":[{"award-number":["R01CA247471"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA247471"],"award-info":[{"award-number":["R01CA247471"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA218545"],"award-info":[{"award-number":["R01CA218545"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Small cell lung cancer (SCLC) is an aggressive lung cancer subtype that is associated with high recurrence and poor prognosis. Due to lack of potential drug targets, SCLC patients have few therapeutic options. MicroRNAs (miRNAs) provide an interesting repertoire of therapeutic molecules; however, the identification of miRNAs regulating SCLC growth and metastasis and their precise regulatory mechanisms are not well understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To identify novel miRNAs regulating SCLC, we performed miRNA-sequencing from donor\/patient serum samples and analyzed the bulk RNA-sequencing data from the tumors of SCLC patients. Further, we developed a nanotechnology-based, highly sensitive method to detect microRNA-1 (miR-1, identified miRNA) in patient serum samples and SCLC cell lines. To assess the therapeutic potential of miR-1, we developed various in vitro models, including miR-1 sponge (miR-1Zip) and DOX-On-miR-1 (Tet-ON) inducible stable overexpression systems. Mouse models derived from intracardiac injection of SCLC cells (miR-1Zip and DOX-On-miR-1) were established to delineate the role of miR-1 in SCLC metastasis. In situ hybridization and immunohistochemistry were used to analyze the expression of miR-1 and target proteins (mouse and human tumor specimens), respectively. Dual-luciferase assay was used to validate the target of miR-1, and chromatin immunoprecipitation\u00a0assay was used to investigate the protein-gene interactions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A consistent downregulation of miR-1 was observed in tumor tissues and serum samples of SCLC patients compared to their matched normal controls, and these results were recapitulated in SCLC cell lines. Gain of function studies of miR-1 in SCLC cell lines showed decreased cell growth and oncogenic signaling, whereas loss of function studies of miR-1 rescued this effect. Intracardiac injection of gain of function\u00a0of miR-1 SCLC cell lines in the mouse models showed a decrease in distant organ metastasis, whereas loss of function of miR-1 potentiated growth and metastasis. Mechanistic studies revealed that CXCR4 is a direct target of miR-1 in SCLC. Using unbiased transcriptomic analysis, we identified CXCR4\/FOXM1\/RRM2 as a unique axis that regulates SCLC growth and metastasis. Our results further showed that FOXM1 directly binds to the RRM2 promoter and regulates its activity in SCLC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings revealed that miR-1 is a critical regulator for decreasing SCLC growth and metastasis. It targets the CXCR4\/FOXM1\/RRM2 axis and has a high potential for the development of novel SCLC therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                    <jats:p>\n                      MicroRNA-1 (miR-1) downregulation in the tumor tissues and serum samples of SCLC\u00a0patients is an important hallmark\u00a0of tumor growth and metastasis. The introduction of miR-1 in SCLC cell lines decreases cell growth and metastasis. Mechanistically, miR-1 directly targets CXCR4, which further prevents FOXM1 binding to the\n                      <jats:italic>RRM2<\/jats:italic>\n                      promoter and decreases SCLC growth and metastasis.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12943-022-01695-6","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T23:30:40Z","timestamp":1672788640000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["MicroRNA-1 attenuates the growth and metastasis of small cell lung cancer through CXCR4\/FOXM1\/RRM2 axis"],"prefix":"10.1186","volume":"22","author":[{"given":"Parvez","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawed Akhtar","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash G.","family":"Kshirsagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramakanth Chirravuri","family":"Venkata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra Kumar","family":"Maurya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Mirzapoiazova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveenkumar","family":"Perumal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjib","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjana Kumari","family":"Kanchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahek","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Arafat","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asad Ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imayavaramban","family":"Lakshmanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidharth","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey A.","family":"Talmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apar K.","family":"Ganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maneesh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Salgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder Kumar","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Wasim","family":"Nasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"issue":"7563","key":"1695_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature14664","volume":"524","author":"J George","year":"2015","unstructured":"George J, et al. Comprehensive genomic profiles of small cell lung cancer. Nature. 2015;524(7563):47\u201353.","journal-title":"Nature"},{"issue":"9962","key":"1695_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0140-6736(14)61252-6","volume":"385","author":"JP van Meerbeeck","year":"2015","unstructured":"van Meerbeeck JP, Ball D. Small-cell lung cancer: local therapy for a systemic disease? Lancet. 2015;385(9962):9\u201310.","journal-title":"Lancet"},{"issue":"9804","key":"1695_CR3","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(11)60165-7","volume":"378","author":"JP van Meerbeeck","year":"2011","unstructured":"van Meerbeeck JP, Fennell DA, De Ruysscher DK. Small-cell lung cancer. Lancet. 2011;378(9804):1741\u201355.","journal-title":"Lancet"},{"issue":"517","key":"1695_CR4","doi-asserted-by":"publisher","first-page":"eaaw7852","DOI":"10.1126\/scitranslmed.aaw7852","volume":"11","author":"L Li","year":"2019","unstructured":"Li L, et al. Identification of DHODH as a therapeutic target in small cell lung cancer. Sci Transl Med. 2019;11(517):eaaw7852.","journal-title":"Sci Transl Med"},{"issue":"5","key":"1695_CR5","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/cncr.29098","volume":"121","author":"LA Byers","year":"2015","unstructured":"Byers LA, Rudin CM. Small cell lung cancer: where do we go from here? Cancer. 2015;121(5):664\u201372.","journal-title":"Cancer"},{"issue":"4","key":"1695_CR6","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jtho.2019.12.109","volume":"15","author":"HC Chung","year":"2020","unstructured":"Chung HC, et al. Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies. J Thorac Oncol. 2020;15(4):618\u201327.","journal-title":"J Thorac Oncol"},{"issue":"10","key":"1695_CR7","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/ng.2405","volume":"44","author":"CM Rudin","year":"2012","unstructured":"Rudin CM, et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat Genet. 2012;44(10):1111\u20136.","journal-title":"Nat Genet"},{"issue":"10","key":"1695_CR8","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/ng.2396","volume":"44","author":"M Peifer","year":"2012","unstructured":"Peifer M, et al. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet. 2012;44(10):1104\u201310.","journal-title":"Nat Genet"},{"issue":"7414","key":"1695_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature11233","volume":"489","author":"S Djebali","year":"2012","unstructured":"Djebali S, et al. Landscape of transcription in human cells. Nature. 2012;489(7414):101\u20138.","journal-title":"Nature"},{"issue":"7006","key":"1695_CR10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350\u20135.","journal-title":"Nature"},{"issue":"2","key":"1695_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215\u201333.","journal-title":"Cell"},{"issue":"5","key":"1695_CR12","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/ng1536","volume":"37","author":"A Krek","year":"2005","unstructured":"Krek A, et al. Combinatorial microRNA target predictions. Nat Genet. 2005;37(5):495\u2013500.","journal-title":"Nat Genet"},{"issue":"18","key":"1695_CR13","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1101\/gad.1820109","volume":"23","author":"P Olson","year":"2009","unstructured":"Olson P, et al. MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Genes Dev. 2009;23(18):2152\u201365.","journal-title":"Genes Dev"},{"issue":"D1","key":"1695_CR14","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","volume":"47","author":"A Kozomara","year":"2019","unstructured":"Kozomara A, Birgaoanu M, Griffiths-Jones S. miRBase: from microRNA sequences to function. Nucleic Acids Res. 2019;47(D1):D155\u201362.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"1695_CR15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrg3471","volume":"14","author":"K Sun","year":"2013","unstructured":"Sun K, Lai EC. Adult-specific functions of animal microRNAs. Nat Rev Genet. 2013;14(8):535\u201348.","journal-title":"Nat Rev Genet"},{"issue":"4","key":"1695_CR16","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.devcel.2006.09.009","volume":"11","author":"WP Kloosterman","year":"2006","unstructured":"Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006;11(4):441\u201350.","journal-title":"Dev Cell"},{"issue":"7048","key":"1695_CR17","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature03817","volume":"436","author":"Y Zhao","year":"2005","unstructured":"Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature. 2005;436(7048):214\u201320.","journal-title":"Nature"},{"issue":"2","key":"1695_CR18","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ng1725","volume":"38","author":"JF Chen","year":"2006","unstructured":"Chen JF, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet. 2006;38(2):228\u201333.","journal-title":"Nat Genet"},{"key":"1695_CR19","doi-asserted-by":"publisher","unstructured":"Khan P, et al. MicroRNA-1: Diverse role of a small player in multiple cancers. Semin Cell Dev Biol. 2022;124:114\u201326. https:\/\/doi.org\/10.1016\/j.semcdb.2021.05.020.","DOI":"10.1016\/j.semcdb.2021.05.020"},{"issue":"21","key":"1695_CR20","doi-asserted-by":"publisher","first-page":"10822","DOI":"10.1021\/acs.analchem.5b01930","volume":"87","author":"W Wang","year":"2015","unstructured":"Wang W, et al. Label-Free MicroRNA Detection Based on Fluorescence Quenching of Gold Nanoparticles with a Competitive Hybridization. Anal Chem. 2015;87(21):10822\u20139.","journal-title":"Anal Chem"},{"issue":"12","key":"1695_CR21","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.1073\/pnas.1019055108","volume":"108","author":"JD Arroyo","year":"2011","unstructured":"Arroyo JD, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 2011;108(12):5003\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1695_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41413-021-00178-6","volume":"10","author":"JA Siddiqui","year":"2022","unstructured":"Siddiqui JA, et al. GDF15 promotes prostate cancer bone metastasis and colonization through osteoblastic CCL2 and RANKL activation. Bone Res. 2022;10(1):6.","journal-title":"Bone Res"},{"issue":"5","key":"1695_CR23","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1053\/j.gastro.2020.07.053","volume":"159","author":"S Karmakar","year":"2020","unstructured":"Karmakar S, et al. RNA Polymerase II-Associated Factor 1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions With PHF5A and DDX3. Gastroenterology. 2020;159(5):1898-1915 e6.","journal-title":"Gastroenterology"},{"key":"1695_CR24","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1038\/oncsis.2016.12","volume":"5","author":"S Chaudhary","year":"2016","unstructured":"Chaudhary S, et al. Overexpression of caspase 7 is ERalpha dependent to affect proliferation and cell growth in breast cancer cells by targeting p21(Cip). Oncogenesis. 2016;5:e219.","journal-title":"Oncogenesis"},{"issue":"4","key":"1695_CR25","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/bpa.12829","volume":"30","author":"RK Kanchan","year":"2020","unstructured":"Kanchan RK, et al. MiR-1253 exerts tumor-suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7\u2013H3). Brain Pathol. 2020;30(4):732\u201345.","journal-title":"Brain Pathol"},{"issue":"1","key":"1695_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12943-022-01498-9","volume":"21","author":"Z Wang","year":"2022","unstructured":"Wang Z, et al. The circROBO1\/KLF5\/FUS feedback loop regulates the liver metastasis of breast cancer by inhibiting the selective autophagy of afadin. Mol Cancer. 2022;21(1):29.","journal-title":"Mol Cancer"},{"issue":"1","key":"1695_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12943-021-01338-2","volume":"20","author":"P Khan","year":"2021","unstructured":"Khan P, et al. RNA-based therapies: A cog in the wheel of lung cancer defense. Mol Cancer. 2021;20(1):54.","journal-title":"Mol Cancer"},{"issue":"1","key":"1695_CR28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12943-021-01477-6","volume":"20","author":"B Zhang","year":"2021","unstructured":"Zhang B, et al. m(6)A target microRNAs in serum for cancer detection. Mol Cancer. 2021;20(1):170.","journal-title":"Mol Cancer"},{"issue":"39","key":"1695_CR29","doi-asserted-by":"publisher","first-page":"24213","DOI":"10.1073\/pnas.2008323117","volume":"117","author":"H Geekiyanage","year":"2020","unstructured":"Geekiyanage H, et al. Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides. Proc Natl Acad Sci U S A. 2020;117(39):24213\u201323.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1695_CR30","doi-asserted-by":"publisher","unstructured":"Kshirsagar P, Seshacharyulu P, Muniyan S, Rachagani S, Smith LM, Thompson C, et al. DNA-gold nanoprobe-based integrated biosensing technology for non-invasive liquid biopsy of serum miRNA: A new frontier in prostate cancer diagnosis. Nanomedicine. 2022;43 Article No: 102566. https:\/\/doi.org\/10.1016\/j.nano.2022.102566.","DOI":"10.1016\/j.nano.2022.102566"},{"issue":"13","key":"1695_CR31","doi-asserted-by":"publisher","first-page":"5049","DOI":"10.1158\/0008-5472.CAN-07-6655","volume":"68","author":"J Datta","year":"2008","unstructured":"Datta J, et al. Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res. 2008;68(13):5049\u201358.","journal-title":"Cancer Res"},{"issue":"3","key":"1695_CR32","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1158\/0008-5472.CAN-13-2650","volume":"74","author":"A Bronisz","year":"2014","unstructured":"Bronisz A, et al. Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1. Cancer Res. 2014;74(3):738\u201350.","journal-title":"Cancer Res"},{"issue":"1","key":"1695_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","volume":"7","author":"CM Rudin","year":"2021","unstructured":"Rudin CM, et al. Small-cell lung cancer. Nat Rev Dis Primers. 2021;7(1):3.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"1695_CR34","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202013122","volume":"13","author":"J Ko","year":"2021","unstructured":"Ko J, Winslow MM, Sage J. Mechanisms of small cell lung cancer metastasis. EMBO Mol Med. 2021;13(1): e13122.","journal-title":"EMBO Mol Med"},{"issue":"3","key":"1695_CR35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s13691-019-00365-7","volume":"8","author":"J Kitazawa","year":"2019","unstructured":"Kitazawa J, et al. Small-cell lung carcinoma with ovarian metastasis 4 years after the first-line treatment. Int Cancer Conf J. 2019;8(3):109\u201313.","journal-title":"Int Cancer Conf J"},{"issue":"14","key":"1695_CR36","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1158\/0008-5472.CAN-17-0299","volume":"77","author":"SK Sharma","year":"2017","unstructured":"Sharma SK, et al. Noninvasive Interrogation of DLL3 Expression in Metastatic Small Cell Lung Cancer. Cancer Res. 2017;77(14):3931\u201341.","journal-title":"Cancer Res"},{"issue":"21","key":"1695_CR37","first-page":"6304","volume":"62","author":"T Kijima","year":"2002","unstructured":"Kijima T, et al. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells. Cancer Res. 2002;62(21):6304\u201311.","journal-title":"Cancer Res"},{"issue":"50","key":"1695_CR38","doi-asserted-by":"publisher","first-page":"8093","DOI":"10.1038\/sj.onc.1207097","volume":"22","author":"M Burger","year":"2003","unstructured":"Burger M, et al. Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells. Oncogene. 2003;22(50):8093\u2013101.","journal-title":"Oncogene"},{"issue":"20","key":"1695_CR39","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1016\/j.febslet.2012.08.011","volume":"586","author":"Y Otani","year":"2012","unstructured":"Otani Y, et al. Suppression of metastases of small cell lung cancer cells in mice by a peptidic CXCR4 inhibitor TF14016. FEBS Lett. 2012;586(20):3639\u201344.","journal-title":"FEBS Lett"},{"issue":"27","key":"1695_CR40","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1038\/sj.onc.1208621","volume":"24","author":"TN Hartmann","year":"2005","unstructured":"Hartmann TN, et al. CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells. Oncogene. 2005;24(27):4462\u201371.","journal-title":"Oncogene"},{"key":"1695_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.lungcan.2016.12.020","volume":"105","author":"R Salgia","year":"2017","unstructured":"Salgia R, et al. A randomized phase II study of LY2510924 and carboplatin\/etoposide versus carboplatin\/etoposide in extensive-disease small cell lung cancer. Lung Cancer. 2017;105:7\u201313.","journal-title":"Lung Cancer"},{"issue":"30","key":"1695_CR42","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.1038\/s41388-021-01895-2","volume":"40","author":"SK Liang","year":"2021","unstructured":"Liang SK, et al. FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis. Oncogene. 2021;40(30):4847\u201358.","journal-title":"Oncogene"},{"issue":"14","key":"1695_CR43","doi-asserted-by":"publisher","first-page":"4480","DOI":"10.1158\/1078-0432.CCR-18-4046","volume":"25","author":"YZ Mazzu","year":"2019","unstructured":"Mazzu YZ, et al. A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2). Clin Cancer Res. 2019;25(14):4480\u201392.","journal-title":"Clin Cancer Res"},{"issue":"18","key":"1695_CR44","doi-asserted-by":"publisher","first-page":"e2100881","DOI":"10.1002\/advs.202100881","volume":"8","author":"W Xiong","year":"2021","unstructured":"Xiong W, et al. RRM2 Regulates Sensitivity to Sunitinib and PD-1 Blockade in Renal Cancer by Stabilizing ANXA1 and Activating the AKT Pathway. Adv Sci (Weinh). 2021;8(18):e2100881.","journal-title":"Adv Sci (Weinh)"},{"key":"1695_CR45","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1038\/ncomms6165","volume":"5","author":"MV Gormally","year":"2014","unstructured":"Gormally MV, et al. Suppression of the FOXM1 transcriptional programme via novel small molecule inhibition. Nat Commun. 2014;5:5165.","journal-title":"Nat Commun"},{"issue":"19","key":"1695_CR46","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1021\/jm00019a017","volume":"38","author":"HC Joao","year":"1995","unstructured":"Joao HC, et al. Quantitative structural activity relationship study of bis-tetraazacyclic compounds. A novel series of HIV-1 and HIV-2 inhibitors. J Med Chem. 1995;38(19):3865\u201373.","journal-title":"J Med Chem"},{"issue":"5","key":"1695_CR47","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41568-019-0133-9","volume":"19","author":"CM Rudin","year":"2019","unstructured":"Rudin CM, et al. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. Nat Rev Cancer. 2019;19(5):289\u201397.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"1695_CR48","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.ccell.2021.09.008","volume":"39","author":"JM Chan","year":"2021","unstructured":"Chan JM, et al. Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer. Cancer Cell. 2021;39(11):1479-1496 e18.","journal-title":"Cancer Cell"},{"issue":"8","key":"1695_CR49","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1158\/2159-8290.CD-20-0913","volume":"11","author":"NR Mahadevan","year":"2021","unstructured":"Mahadevan NR, et al. Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity. Cancer Discov. 2021;11(8):1952\u201369.","journal-title":"Cancer Discov"},{"issue":"20","key":"1695_CR50","first-page":"8870","volume":"23","author":"J Ke","year":"2019","unstructured":"Ke J, et al. MiR-1-3p suppresses cell proliferation and invasion and targets STC2 in gastric cancer. Eur Rev Med Pharmacol Sci. 2019;23(20):8870\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"16","key":"1695_CR51","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1016\/j.febslet.2010.07.027","volume":"584","author":"ZX Shan","year":"2010","unstructured":"Shan ZX, et al. miR-1\/miR-206 regulate Hsp60 expression contributing to glucose-mediated apoptosis in cardiomyocytes. FEBS Lett. 2010;584(16):3592\u2013600.","journal-title":"FEBS Lett"},{"issue":"12","key":"1695_CR52","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/s41590-019-0542-7","volume":"20","author":"H Xu","year":"2019","unstructured":"Xu H, et al. Inducible degradation of lncRNA Sros1 promotes IFN-gamma-mediated activation of innate immune responses by stabilizing Stat1 mRNA. Nat Immunol. 2019;20(12):1621\u201330.","journal-title":"Nat Immunol"},{"issue":"10","key":"1695_CR53","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1200\/JCO.2009.24.9342","volume":"28","author":"Z Hu","year":"2010","unstructured":"Hu Z, et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol. 2010;28(10):1721\u20136.","journal-title":"J Clin Oncol"},{"key":"1695_CR54","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.semcancer.2022.11.005","volume":"87","author":"P Khan","year":"2022","unstructured":"Khan P, et al. Emerging role of chemokines in small cell lung cancer: Road signs for metastasis, heterogeneity, and immune response. Semin Cancer Biol. 2022;87:117\u201326.","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"1695_CR55","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/ncb1217","volume":"7","author":"J Laoukili","year":"2005","unstructured":"Laoukili J, et al. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol. 2005;7(2):126\u201336.","journal-title":"Nat Cell Biol"},{"issue":"9","key":"1695_CR56","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1093\/nar\/25.9.1715","volume":"25","author":"W Korver","year":"1997","unstructured":"Korver W, Roose J, Clevers H. The winged-helix transcription factor Trident is expressed in cycling cells. Nucleic Acids Res. 1997;25(9):1715\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"48","key":"1695_CR57","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1038\/onc.2009.282","volume":"28","author":"AM Barsotti","year":"2009","unstructured":"Barsotti AM, Prives C. Pro-proliferative FoxM1 is a target of p53-mediated repression. Oncogene. 2009;28(48):4295\u2013305.","journal-title":"Oncogene"},{"issue":"3","key":"1695_CR58","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s10637-017-0446-z","volume":"35","author":"R Salgia","year":"2017","unstructured":"Salgia R, et al. Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study. Invest New Drugs. 2017;35(3):334\u201344.","journal-title":"Invest New Drugs"},{"issue":"6","key":"1695_CR59","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1158\/1535-7163.MCT-11-0024","volume":"10","author":"J Millour","year":"2011","unstructured":"Millour J, et al. ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance. Mol Cancer Ther. 2011;10(6):1046\u201358.","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"1695_CR60","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1158\/2159-8290.CD-18-0389","volume":"9","author":"MG Oser","year":"2019","unstructured":"Oser MG, et al. Cells Lacking the RB1 Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival. Cancer Discov. 2019;9(2):230\u201347.","journal-title":"Cancer Discov"},{"key":"1695_CR61","doi-asserted-by":"crossref","unstructured":"D\u2019Angiolella V, et al. Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair. Cell. 2012;149(5):1023\u201334.","DOI":"10.1016\/j.cell.2012.03.043"},{"key":"1695_CR62","doi-asserted-by":"publisher","first-page":"13398","DOI":"10.1038\/ncomms13398","volume":"7","author":"RD Rasmussen","year":"2016","unstructured":"Rasmussen RD, et al. BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicity. Nat Commun. 2016;7:13398.","journal-title":"Nat Commun"},{"issue":"1","key":"1695_CR63","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ccell.2015.06.002","volume":"28","author":"HP Mohammad","year":"2015","unstructured":"Mohammad HP, et al. A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC. Cancer Cell. 2015;28(1):57\u201369.","journal-title":"Cancer Cell"},{"issue":"567","key":"1695_CR64","doi-asserted-by":"publisher","first-page":"eaau2922","DOI":"10.1126\/scisignal.aau2922","volume":"12","author":"A Augert","year":"2019","unstructured":"Augert A, et al. Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition. Sci Signal. 2019;12(567):eaau2922.","journal-title":"Sci Signal"},{"issue":"11","key":"1695_CR65","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1158\/2159-8290.CD-18-0385","volume":"8","author":"D Jia","year":"2018","unstructured":"Jia D, et al. Crebbp loss drives small cell lung cancer and increases sensitivity to HDAC inhibition. Cancer Discov. 2018;8(11):1422\u201337.","journal-title":"Cancer Discov"},{"key":"1695_CR66","doi-asserted-by":"publisher","unstructured":"Khan P, et al. Epigenetic landscape of small cell lung cancer: small image of a giant recalcitrant disease. Semin Cancer Biol. 2022;83:57\u201376. https:\/\/doi.org\/10.1016\/j.semcancer.2020.11.006.","DOI":"10.1016\/j.semcancer.2020.11.006"},{"issue":"2","key":"1695_CR67","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ccell.2017.01.006","volume":"31","author":"EE Gardner","year":"2017","unstructured":"Gardner EE, et al. Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis. Cancer Cell. 2017;31(2):286\u201399.","journal-title":"Cancer Cell"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-022-01695-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-022-01695-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-022-01695-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T21:02:47Z","timestamp":1673125367000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-022-01695-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1695"],"URL":"https:\/\/doi.org\/10.1186\/s12943-022-01695-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1538869\/v1","asserted-by":"object"}]},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"assertion":[{"value":"8 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All mouse experiments\/procedures were duly approved and performed as per Institutional animal care and use committee (IACUC) guidelines in accordance with the National Institute of Health (NIH). The animals were maintained as per IACUC guidelines in the University of Nebraska medical center (UNMC) animal house facility (IACUC # 17\u2013045-06-FC).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree with the content of the manuscript and consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SKB is co-founder of Sanguine Diagnostics and Therapeutics, Inc. AKG has served on Advisory Boards for AstraZeneca, Jazz pharmaceuticals, Sanofi\u2013Genzyme, Beigene; received research support from Takeda Pharmaceuticals, Merck, TAB Biosciences, IOVANCE, and Mirati Therapeutics; is a consultant for Flagship Biosciences and serves on the DSMC for Y-mAbs Therapeutics. Other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}